Scotoma Reduction in AMD Patients Treated With Ranibizumab

Part of paid clinical trials in Slingerlands, New York.

Sponsor
Retina Research Foundation
Study ID
NCT00467935
Phase
PHASE1/PHASE2
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
50 Years - 90 Years
Healthy Volunteers
Not accepted

Interventions

Study Details

This is a trial aimed at patients with advanced wet macular degeneration and macular scarring treated wiht intravitreal injections of Lucentis.

Key Dates

First listed
May 1, 2007
Start date
Mar 31, 2007
Status verified
Jul 2011
Primary completion
Nov 30, 2007
Completion
Nov 30, 2007

Study Design

Enrollment
20 participants (estimated)
Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Primary Outcome Measure

scotoma reduction [ Time Frame: 12 months ]

Locations (1)

FacilityCityStateZIPSite coordinators
Retina Research CenterSlingerlandsNew York12159-

Find similar trials in Slingerlands, NY

By condition
Age-related macular degeneration
By specialty
OphthalmologyRetina
By research site
Retina Research Center· Slingerlands, NY

Related Studies